{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:03:26Z","timestamp":1748491406485,"version":"3.41.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,28]]},"DOI":"10.7759\/cureus.84943","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T09:30:02Z","timestamp":1748424602000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Composite Lymphoma in an Elderly Man: A Case of Marginal Zone Lymphoma With Classic Hodgkin Features Treated With Brentuximab and Immunotherapy"],"prefix":"10.7759","author":[{"given":"Muhammad","family":"Daniyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamm","family":"Polani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrat","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Raja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcy","family":"Canary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Composite lymphoma","volume":"40","author":"Kim H","year":"1977","unstructured":"Kim H, Hendrickson MR, Dorfman RF. Composite lymphoma. Cancer. 1977, 40:959-76.","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.17116\/patol20198103159","article-title":"Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th edition): lymphoid tumors (Article in Russian)","volume":"81","author":"Polyatskin IL","year":"2019","unstructured":"Polyatskin IL, Artem'eva AS, Krivolapov YA. Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th edition): lymphoid tumors (Article in Russian). Arkh Patol. 2019, 81:59-65.","journal-title":"Arkh Patol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800327","article-title":"Combined laser capture microdissection and serial analysis of gene expression from human tissue samples","volume":"18","author":"Cho-Vega JH","year":"2005","unstructured":"Cho-Vega JH, Troncoso P, Do KA, et al.. Combined laser capture microdissection and serial analysis of gene expression from human tissue samples. Mod Pathol. 2005, 18:577-84. 10.1038\/modpathol.3800327","journal-title":"Mod Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2013.08.004","article-title":"Single-agent liposomal all-trans-retinoic acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up data","volume":"14","author":"Jain P","year":"2014","unstructured":"Jain P, Kantarjian H, Estey E, Pierce S, Cortes J, Lopez-Berestein G, Ravandi F. Single-agent liposomal all-trans-retinoic acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up data. Clin Lymphoma Myeloma Leuk. 2014, 14:e47-9. 10.1016\/j.clml.2013.08.004","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2010-0213","article-title":"EBV-positive diffuse large B-cell lymphoma of the elderly: what we know so far","volume":"16","author":"Castillo JJ","year":"2011","unstructured":"Castillo JJ, Beltran BE, Miranda RN, Paydas S, Winer ES, Butera JN. EBV-positive diffuse large B-cell lymphoma of the elderly: what we know so far. Oncologist. 2011, 16:87-96.","journal-title":"Oncologist"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/96.1.81","article-title":"Composite lymphoma: a clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma","volume":"96","author":"Gonzalez CL","year":"1991","unstructured":"Gonzalez CL, Medeiros LJ, Jaffe ES. Composite lymphoma: a clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma. Am J Clin Pathol. 1991, 96:81-9. 10.1093\/ajcp\/96.1.81","journal-title":"Am J Clin Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr2929w","article-title":"Composite lymphoma: opposite ends of spectrum meet","volume":"9","author":"Khan U","year":"2017","unstructured":"Khan U, Hadid T, Ibrar W, Sano D, Al-Katib A. Composite lymphoma: opposite ends of spectrum meet. J Clin Med Res. 2017, 9:213-215. 10.14740\/jocmr2929w","journal-title":"J Clin Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708984","article-title":"Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma","volume":"378","author":"Connors JM","year":"2018","unstructured":"Connors JM, Jurczak W, Straus DJ, et al.. Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma. N Engl J Med. 2018, 378:331-44. 10.1056\/NEJMoa1708984","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.0793","article-title":"Nivolumab for relapsed\/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial","volume":"36","author":"Armand P","year":"2018","unstructured":"Armand P, Engert A, Younes A, et al.. Nivolumab for relapsed\/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial. J Clin Oncol. 2018, 36:1428-39. 10.1200\/JCO.2017.76.0793","journal-title":"J Clin Oncol"},{"key":"ref10","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Hodgkin lymphoma. Version 1. (2024). https:\/\/www.nccn.org."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.133801","article-title":"Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis","volume":"55","author":"Pak K","year":"2014","unstructured":"Pak K, Cheon GJ, Nam HY, et al.. Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis. J Nucl Med. 2014, 55:884-90. 10.2967\/jnumed.113.133801","journal-title":"J Nucl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/260197-recurrent-composite-lymphoma-in-an-elderly-man-a-case-of-marginal-zone-lymphoma-with-classic-hodgkin-features-treated-with-brentuximab-and-immunotherapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T09:30:08Z","timestamp":1748424608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/260197-recurrent-composite-lymphoma-in-an-elderly-man-a-case-of-marginal-zone-lymphoma-with-classic-hodgkin-features-treated-with-brentuximab-and-immunotherapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.84943","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,28]]}}}